Vascular involvement in systemic sclerosis (scleroderma)

Postlethwaite, Pattanaik, Debendra, Brown, Monica·2011·Journal of Inflammation Research
DOI 10.2147/jir.s18145

Cites (251)

Items 201–249 of 249

  1. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: Influence on disease outcome
    Derek L. Mattey, ANDREW B. HASSELL, Peter T Dawes, William Ollier, Ali H. Hajeer · 1999 · Arthritis & Rheumatism
  2. Clinical perspectives of calcitonin gene related peptide pharmacology
    G. Z. FEUERSTEIN, Robert N. Willette, Nambi V. Aiyar · 1995 · Canadian Journal of Physiology and Pharmacology
  3. Assessment of vascular involvement.
    Bashar Kahaleh, Olivier Meyer, R Scorza · 2003 · PubMed
  4. Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V
    Ruedi K. Braun, Alicia A. Martin, Shivanee Shah, Makio Iwashima, Melissa G. Medina, Kathryn Byrne, Periannan Sethupathi, Christopher H. Wigfield, David Douglass Brand, Robert B. Love · 2010 · The Journal of Heart and Lung Transplantation
  5. Autoantibody profile in the experimental model of scleroderma induced by type V human collagen
    Maria Roseli Monteiro Callado, Vilma S. T. Viana, Margarete B. G. Vendramini, Elaine Pires Leon, Cleonice Bueno, Ana Paula Pereira Velosa, Walcy Rosólia Teodoro, Natalino H. Yoshinari · 2007 · Immunology
  6. Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis
    M. J. D. Goodfield, Margaret A. Orchard, N.R. Rowell · 1993 · British Journal of Haematology
  7. Novel Functions of Intracellular IL-1ra in Human Dermal Fibroblasts: Implications in the Pathogenesis of Fibrosis
    Kanangat, Siva, Postlethwaite, Arnold E., Higgins, Gloria C., Hasty, Karen A. · 2006 · Journal of Investigative Dermatology
  8. The genetics of systemic sclerosis.
    Sandeep Krishna Agarwal · 2010 · PubMed
  9. Platelet-Derived Growth Factor-BB and Lysophosphatidic Acid Distinctly Regulate Hepatic Myofibroblast Migration through Focal Adhesion Kinase
    Pisit Tangkijvanich, Andrew C. Melton, Taned Chitapanarux, Jiu Han, Hal F. Yee · 2002 · Experimental Cell Research
  10. The pathogenesis of fibrosis and renal disease in scleroderma: Recent insights from glomerulosclerosis
    Sungchun Lee, Sohee Lee, Kumar Sharma · 2004 · Current Rheumatology Reports
  11. Alterations in the regulation of expression of the αl(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma)
    Sergio A. Jiménez, Biagio Saitta · 2000 · Springer Seminars in Immunopathology
  12. ELECTRON MICROSCOPIC OBSERVATIONS ON SKELETAL MUSCLE IN DIFFUSE SCLERODERMA.
    Roman Michałowski, Jan Kudejko · 1966 · British Journal of Dermatology
  13. Bosentan
    Sohita Dhillon · 2009 · Drugs
  14. A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.
    Debendra Pattanaik, Arnold E. Postlethwaite · 2010 · PubMed
  15. Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication
    Alfonso J De LaVega, Chris T. Derk · 2008 · Expert Opinion on Investigational Drugs
  16. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
    G C Higgins, Y Wu, Arnold E. Postlethwaite · 1999 · PubMed
  17. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor–beta1
    Guido Serini, Marie-luce Bochaton-piallat, Patricia Ropraz, Antoine Geinoz, Laura Borsi, Luciano Zardi, Giulio Gabbiani · 1998
  18. Neuronal Regulators and Vascular Dysfunction in Raynauds Phenomenon and Systemic Sclerosis
    Carmen Fonseca, David Abraham, Markella Ponticos · 2009 · Current Vascular Pharmacology
  19. Characterisation of the immune response to type I collagen in scleroderma
    Kenneth J. Warrington, Usha Nair, Laura D. Carbone, Andrew H. Kang, Arnold E. Postlethwaite · 2006 · Arthritis Research & Therapy
  20. Scleroderma (systemic sclerosis) among Nigerians
    OO Adelowo, Akintayo Segun Oguntona · 2009 · Clinical Rheumatology
  21. Targeted therapy for systemic sclerosis: how close are we?
    Manuel Ramos‐Casals, Vicent Fonollosa‐Pla, Pilar Brito‐Zerón, Antoni Sisó‐Almirall · 2010 · Nature Reviews Rheumatology
  22. Endothelial-dependent vasodilation is impaired in patients with systemic sclerosis, as assessed by low dose iontophoresis.
    Marina Anderson, TONIA L. MOORE, Sally Hollis, Stuart Clark, Malcolm I. V. Jayson, Ariane L. Herrick · 2003 · PubMed
  23. Drug Treatment of Scleroderma
    Carol Leighton · 2001 · Drugs
  24. What are the new milestones in the pathogenesis of systemic sclerosis?
    Nicolas Hunzelmann, Jürgen Brinckmann · 2009 · Annals of the Rheumatic Diseases
  25. Pharmacotherapy of systemic sclerosis
    Arnold E. Postlethwaite, L. Jeff Harris, Syed Hasan Raza, Swapna Kodura, Titilola Akhigbe · 2010 · Expert Opinion on Pharmacotherapy
  26. Serotonin induced platelet aggregation in systemic sclerosis.
    Lawrence T. Friedhoff, James R. Seibold, H C Kim, K S Simester · 1984 · PubMed
  27. Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis
    Gian Luca Erre, Giuseppe Passiu · 2011 · Reumatismo
  28. Modulation of myocardial contractility by lysophosphatidic acid (LPA)
    Bodo Cremers · 2003 · Journal of Molecular and Cellular Cardiology
  29. Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
    Zhimin Yin, Laura D. Carbone, Mari Gotoh, Arnold E. Postlethwaite, Alyssa L. Bolen, Gábor Tigyi, Kimiko Murakami‐Murofushi, Mitchell A. Watsky · 2010 · Lara D. Veeken
  30. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: A potential treatment
    Namita Kumar, Bridget Griffiths, John Allen · 2006 · PubMed
  31. 055 Cross-talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia
    Saadia Eddahibi · 2006 · Revue des Maladies Respiratoires
  32. Long-Term Outcomes of Scleroderma Renal Crisis
    2000 · Annals of Internal Medicine
  33. Prostacyclin Analogue Iloprost Influences Endothelial Cell-associated Soluble Adhesion Molecules and Growth Factors in Patients with Systemic Sclerosis: A Time Course Study of Serum Concentrations
    Philipp Rehberger, P. Beckheinrich, U-F Haustein, Michael Sticherling · 2009 · Acta Dermato Venereologica
  34. Successful Treatment of Systemic-Sclerosis-Related Digital Ulcers with a Selective Endothelin Type A Receptor Antagonist (Sitaxentan)
    Patrick Gholam, Tony Sehr, Alexander Enk, M. Hartmann · 2009 · Dermatology
  35. Autopsy case of systemic sclerosis with severe pulmonary hypertension
    Yayoi Nagai, Masayoshi Yamanaka, Chie Hashimoto, Akihiko Nakano, Akira Hasegawa, Yuko Tanaka, Hideaki Yokoo, Yoichi Nakazato, Osamu Ishikawa · 2007 · The Journal of Dermatology
  36. Lysophosphatidic Acid and Renal Fibrosis
    Jenq‐Wen Huang, Hui‐Teng Cheng, Chih‐Kang Chiang, Kuan‐Yu Hung, Tun‐Jun Tsai · 2008 · Recent Patents on Endocrine Metabolic & Immune Drug Discovery
  37. Epidemiology and classification of scleroderma
    Maureen Davidica Mayes, Shervin Assassi · 2011 · Elsevier eBooks
  38. Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)
    Sergei P. Atamas, Irina G. Luzina, Jesse F. Ingels, Jin‐Ho Choi, W K Wong, Daniel E. Furst, Philip J. Clements, Investigators of the Oral Collagen Trial in Scleroderma, A E Postlethwaite · 2010 · Clinical & Experimental Immunology
  39. A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis
    Thomas M. Chiang, Arnold E. Postlethwaite · 2007 · Biochimica et Biophysica Acta (BBA) - General Subjects
  40. Genetics of Systemic Sclerosis
    Giuseppe Murdaca, Ottavia Magnani, Francesco Puppo · 2018 · Encyclopedia of Life Sciences
  41. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
    David Launay, Élisabeth Diot, Élisabeth Pasquier, Luc Mouthon, Nadine Boullanger, O. Fain, P. Jégo, P. Carpentier, Pierre‐Yves Hatron, Eric HACHULLA · 2006 · HAL
  42. Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?
    Eric HACHULLA, David Launay, Pierre Clerson, Marc J.C. Humbert · 2010 · CHEST Journal
  43. Unusual presentation of progressive systemic sclerosis.
    S U Chowdhury, M A Miah, Mahdia Mahmud, S I Talukder, M N Islam, N Islam · 2008 · PubMed
  44. Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease
    A G Franks · 1987 · De Gruyter eBooks
  45. A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: Comment on the article by Seibold et al
    Markus Bredemeier · 2010 · Arthritis & Rheumatism
  46. Diagnosis and management of systemic sclerosis
    Dinesh Khanna · 2010 · Indian Journal of Rheumatology
  47. Alteration in protein kinase B (AKT) activity in platelets from patients with systemic sclerosis
    Thomas M. Chiang, Arnold E. Postlethwaite · 2008 · Thrombosis Research
  48. Untitled work
    1998 · 10.1002/1529-0131(199806)41:6
  49. Untitled work
    Shigeyama · 2000 · 10.1002/1529-0131(200011)43:11